Retinoblastoma — Trials

Retinoblastoma — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 8
Ph III recruiting: 3
Growth YoY: —
Industry share: 7%
Top sponsor: Institut Curie
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02116959	Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma	terminated	Phase 1	6	University of California, San FranciscoOTHER	1	Apr 16, 2020	clinicaltrials
NCT00623077	MT2004-30: Tomotherapy for Solid Tumors	terminated	Phase 1	23	Masonic Cancer Center, University of MinnesotaOTHER	1	Dec 5, 2017	clinicaltrials